Arcutis Biotherapeutics Inc (ARQT)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -260.697 | -70.124 | -53.123 | -66.955 | -58.423 | -72.65 | -66.311 |
| Return on Equity (%) | 199.399 | 132.885 | 94.356 | -131.988 | -72.622 | -122.801 | -175.787 |
| Return on Invested Capital (%) | -380.009 | -78.273 | -57.632 | -73.473 | -64.491 | -77.537 | -69.846 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -8025.122 | -384.718 |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -8449.756 | -439.788 |
| Book Value Per Share | 2.341 | 30.979 | 47.837 | 6.244 | 5.923 | 3.316 | 0.871 |
| Earnings Per Share | -5.393 | -12.359 | -19.8 | -3.131 | -4.106 | -5.103 | -2.777 |
| Cash Per Share | 3.703 | 25.285 | 29.861 | 1.502 | 1.919 | 0.879 | 0.937 |
| Working Capital Per Share | 3.388 | 31.082 | 47.731 | 6.235 | 7.351 | 6.547 | 3.007 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.048 | 0.595 |
| EBIT Per Share | -5.393 | -12.359 | -19.8 | -3.131 | -4.106 | -5.103 | -2.744 |
| EBITDA Per Share | -5.393 | -12.359 | -19.8 | -3.131 | -4.106 | -5.103 | -2.744 |
| Free Cash Flow Per Share | -5.393 | -12.359 | -19.693 | -3.126 | -4.095 | -4.737 | -2.789 |
| Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 923k | 1.56M | 2.12M | 43.34M | 50.26M | 61.04M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
| Shares Outstanding | 61.04M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -2627.041 | N/A | N/A | N/A | -55.636 | N/A | N/A |
| Net Profit Margin (%) | N/A | -2880.259 | N/A | N/A | N/A | -71.379 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.61B |
| Price to Earnings Ratio | -5.65 |
| Price to Sales Ratio | 24.84 |
| Price to Cash Ratio | 16.75 |
| Price to Book Ratio | 16.7 |
| Dividend Yield | - |
| Shares Outstanding | 117.04M |
| Average Volume (1 week) | 1.84M |
| Average Volume (1 Month) | 2M |
| 52 Week Change | 275.52% |
| 52 Week High | 16.20 |
| 52 Week Low | 3.1101 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
